Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common stock, par value $0.00001
-
Shares outstanding
-
4.45M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
225K
-
Shares change
-
-132K
-
Total reported value, excl. options
-
$87.5K
-
Value change
-
-$66.7K
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$0.39
Significant Holders of Shuttle Pharmaceuticals Holdings, Inc. - Common stock, par value $0.00001 (SHPH) as of Q1 2025
8 filings reported holding SHPH - Shuttle Pharmaceuticals Holdings, Inc. - Common stock, par value $0.00001 as of Q1 2025.
Shuttle Pharmaceuticals Holdings, Inc. - Common stock, par value $0.00001 (SHPH) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 225K shares
of 4.45M outstanding shares and own 5.05% of the company stock.
Largest 8 shareholders include CITADEL ADVISORS LLC (94.9K shares), ARMISTICE CAPITAL, LLC (70.4K shares), GEODE CAPITAL MANAGEMENT, LLC (33.9K shares), TWO SIGMA SECURITIES, LLC (22.2K shares), Tower Research Capital LLC (TRC) (3.4K shares), Federation des caisses Desjardins du Quebec (63 shares), BANK OF AMERICA CORP /DE/ (26 shares), and UBS Group AG (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.